Our Commitment

Infraredx is committed to working collaboratively with physicians to improve the diagnosis and resulting treatment of vascular disease by applying proprietary advanced technologies.

The company and its technology are deeply rooted in rigorous science and solid data. Findings have published in numerous peer-reviewed publications and have been presented at industry conferences.

You can view these data on the Publications page.

Most importantly, Infraredx is committed to maintaining the highest standards for its products and technologies – from research and development, to sales and marketing, to product support.

Robert McNeil, Managing Director at Sanderling Ventures discusses the importance of lipid core plaque (LCP) detection using the TVC Imaging System. He emphasizes the need to detect LCPs with the intention of reducing post PCI complications and associated cost.
© Infraredx, Inc. All rights reserved. Terms of Service | Site Map